Ermium receives 800 000 € from Bpifrance, the French Innovation agency

Ermium has been granted 800 000 € as “aide à l’innovation” (Innovation support) from Bpifrance, the French agency for innovation, to further advance its therapeutic approach for auto-immune diseases including systemic lupus erythematosus, Sjögren’s syndrome and other type I interferon driven diseases